ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,865
0,28%
Bitcoin
59 802,55
1,15%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Pfizer Inc (PFE)

  7. Pfizer Inc (PFE) Actualités

PFE

Pfizer (PFE)

Pfizer Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:PFE
DateHeureSourceTitreSymboleSociété
01/05/202415h12IH Market NewsCVS Health, Starbucks, Shares Weaker; Pinterest SoarsNYSE:PFEPfizer Inc
01/05/202412h45Business WirePfizer Reports First-Quarter 2024 ResultsNYSE:PFEPfizer Inc
30/04/202400h40Business WireTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
30/04/202400h40Business WireFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
29/04/202412h45Business WirePfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual MeetingNYSE:PFEPfizer Inc
26/04/202413h48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNYSE:PFEPfizer Inc
26/04/202412h45Business WireU.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia BNYSE:PFEPfizer Inc
24/04/202422h37Business WirePfizer Declares Second-Quarter 2024 DividendNYSE:PFEPfizer Inc
24/04/202413h28IH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNYSE:PFEPfizer Inc
22/04/202414h08Business WireEuropean Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsNYSE:PFEPfizer Inc
11/04/202416h00Business WirePfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25NYSE:PFEPfizer Inc
10/04/202413h13IH Market NewsDelta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More NewsNYSE:PFEPfizer Inc
09/04/202412h45Business WirePfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV DiseaseNYSE:PFEPfizer Inc
08/04/202418h44PR Newswire (US)ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering ManagerNYSE:PFEPfizer Inc
26/03/202412h20IH Market NewsSuper Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest NewsNYSE:PFEPfizer Inc
21/03/202412h17IH Market NewsApple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market UpdatesNYSE:PFEPfizer Inc
20/03/202415h00Business WirePfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with AnalystsNYSE:PFEPfizer Inc
19/03/202412h33IH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNYSE:PFEPfizer Inc
18/03/202412h10IH Market NewsApple & Google in Talks for Gemini AI on iPhone, Nvidia’s GTC Conference Today, and Latest NewsNYSE:PFEPfizer Inc
13/03/202409h00Business WireEuropean Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal DiseaseNYSE:PFEPfizer Inc
12/03/202411h45Business WirePfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)NYSE:PFEPfizer Inc
05/03/202421h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
05/03/202416h00Business WirePfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ConferenceNYSE:PFEPfizer Inc
05/03/202415h03IH Market NewsFutures Pointing To Continued Weakness On Wall StreetNYSE:PFEPfizer Inc
29/02/202423h40Business WirePfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable GrowthNYSE:PFEPfizer Inc
29/02/202414h00Business WirePfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older AdultsNYSE:PFEPfizer Inc
27/02/202415h14IH Market NewsU.S. Stocks May Lack Direction Following Yesterday’s Modest PullbackNYSE:PFEPfizer Inc
23/02/202422h34Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:PFEPfizer Inc
23/02/202422h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:PFEPfizer Inc
22/02/202419h17Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:PFEPfizer Inc
 Showing the most relevant articles for your search:NYSE:PFE

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
EU
DG
Vinci
EU
AI
Air Liquide
NYSE
JPM
JP Morgan Chase
EU
HO
Thales
NYSE
NKE
Nike
NASDAQ
AAPL
Apple
SPI
SP500
S&P 500
EU
CS
Axa
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
EU
RNO
Renault
EU
BNP
BNP Paribas
EU
ORA
Orange
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés